• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Contact Us

Sign In

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends

Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends

by Truveta Research | Jun 6, 2023 | Research, Research Insights

Beginning in Fall 2022, the news media has reported extensively on the use of Glucagon-like peptide-1 receptor agonist (GLP-1s) for weight loss (Belluz, 2023). Physicians have taken to TikTok to promote GLP-1s for weight loss, and celebrities & influencers – such...

Recent posts

  • Advancing epilepsy research: Insights from Truveta’s epilepsy data
  • Truveta and Mathematica partner to advance public health and health equity with real-world data
  • Medical Components, Inc. and Truveta: Using real-world data to improve patient care


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.